Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
FRC transplantation restores lymph node conduit defects in laminin α4–deficient mice
Lushen Li, Long Wu, Allison Kensiski, Jing Zhao, Marina W. Shirkey, Yang Song, Wenji Piao, Tianshu Zhang, Zhongcheng Mei, Samuel J. Gavzy, Bing Ma, Vikas Saxena, Young S. Lee, Yanbao Xiong, Xiaofei Li, Xiaoxuan Fan, Reza Abdi, Jonathan S. Bromberg
Lushen Li, Long Wu, Allison Kensiski, Jing Zhao, Marina W. Shirkey, Yang Song, Wenji Piao, Tianshu Zhang, Zhongcheng Mei, Samuel J. Gavzy, Bing Ma, Vikas Saxena, Young S. Lee, Yanbao Xiong, Xiaofei Li, Xiaoxuan Fan, Reza Abdi, Jonathan S. Bromberg
View: Text | PDF
Research Article Immunology

FRC transplantation restores lymph node conduit defects in laminin α4–deficient mice

  • Text
  • PDF
Abstract

Fibroblastic reticular cells (FRCs) play important roles in tolerance by producing laminin α4 (Lama4) and altering lymph node (LN) structure and function. The present study revealed the specific roles of extracellular matrix Lama4 in regulating LN conduits using FRC-specific KO mouse strains. FRC-derived Lama4 maintained conduit fiber integrity, as its depletion altered conduit morphology and structure and reduced homeostatic conduit flow. Lama4 regulated the lymphotoxin β receptor (LTβR) pathway, which is critical for conduit and LN integrity. Depleting LTβR in FRCs further reduced conduits and impaired reticular fibers. Lama4 was indispensable for FRC generation and survival, as FRCs lacking Lama4 displayed reduced proliferation but upregulated senescence and apoptosis. During acute immunization, FRC Lama4 deficiency increased antigen flow through conduits. Importantly, adoptive transfer of WT FRCs to FRC Lama4–deficient mice rescued conduit structure, ameliorated Treg and chemokine distribution, and restored transplant allograft acceptance, which were all impaired by FRC Lama4 depletion. Single-cell RNA sequencing analysis of LN stromal cells indicated that the laminin and collagen signaling pathways linked crosstalk among FRC subsets and endothelial cells. This study demonstrated that FRC Lama4 is responsible for maintaining conduits by FRCs and can be harnessed to potentiate FRC-based immunomodulation.

Authors

Lushen Li, Long Wu, Allison Kensiski, Jing Zhao, Marina W. Shirkey, Yang Song, Wenji Piao, Tianshu Zhang, Zhongcheng Mei, Samuel J. Gavzy, Bing Ma, Vikas Saxena, Young S. Lee, Yanbao Xiong, Xiaofei Li, Xiaoxuan Fan, Reza Abdi, Jonathan S. Bromberg

×

Figure 1

Lymph node FRCs support conduits.

Options: View larger image (or click on image) Download as PowerPoint
Lymph node FRCs support conduits.
C57BL/6 WT mice received 2.5 μg dextra...
C57BL/6 WT mice received 2.5 μg dextran-FITC (40 kDa) s.c. at the tail base. Five minutes after injection, the inguinal draining lymph nodes (dLNs) were collected. (A) Conduits colocalized with ER-TR7 but not with Lyve-1 and conventional DCs (cDCs). Arrows point to yellow resulting from the overlap of dextran-FITC (green) and ER-TR7 (red) signals. LN cryosections (6 μm) were stained for Lyve-1, ER-TR7, and CD11c. Original magnification, ×20. Scale bars: 100 μm (top) and 25 μm (bottom). (B) 3D confocal immunofluorescence microscopy with 50-μm cryosection stained for ER-TR7 and Pdpn. Representative image shows the CR region. Scale bar: 30 μm. (C) Conduits colocalized with ER-TR7 and Pdpn. Left: Sections (6 μm) stained for ER-TR7 and Pdpn. Original magnification, ×20. Scale bars: 100 μm (top) and 25 μm (bottom). Arrows point to conduits that are colocalized with ER-TR7 and Pdpn. Right: Pearson’s correlation for colocalization of dextran-FITC with ER-TR7 or Pdpn in the CR, T zone, medulla, and B zone. (D) Depleting LN FRCs impaired the conduit system. CCL19/iDTR mice received diphtheria toxin (DT) (100 ng/day i.p. for 5 days) for FRC depletion. Mice were then injected s.c. with 2.5 μg dextran-FITC (40 kDa) and dLNs harvested after 5 minutes. Left: Whole-mount scanning image s (×20) of 6-μm LN cryosections stained for ER-TR7 and Pdpn. Scale bars: 500 μm (left) and 50 μm (enlarged). Arrows point to high endothelial venules (HEVs). Right: Quantification of dextran-FITC intensity in the CR, T zone, medulla, B follicles, and around HEVs; 3 mice/group, 5 LNs/mouse, 3 sections/LN, 3–5 fields/section. Data presented as mean ± SEM. *P < 0.05, ****P < 0.0001 by 2-tailed Student’s t test for 2-group comparisons.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts